Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Leon Cooperman Sells $F, Reduces $UAL and Goes Crazy for $RIMM

Leon Cooperman, the billionaire behind Omega Advisors really shook things up in the third quarter. He sold out of big positions in large cap companies and placed bets on a few businesses that have had iffy performance.

Leon Cooperman Sold Position in Ford, Cut $UAL

Leon Cooperman reduced his portfolio from $4.4 billion at the end of June to $3.4 billion at the end of the third quarter. Cooperman also reduced the number of his positions. He had had 70 positions in June and now has just 59 positions. Cooperman completely sold out of Ford (F) and slashed his stake in United Continental (UAL).

OMEGA ADVISORS

Leon Cooperman Makes Big Bets on $RIMM, Others

Leon Cooperman is bullish on Reseearch in Motion (RIMM), the company that makes BlackBerry. RIMM has fallen almost 70% this year on competition from iPhone and Android phones and technical issues plaguing the BlackBerry platform. He bought a new position in the company in the third quarter of 1.425 million shares. Cooperman increased his stake in eBay (EBAY) and E*Trade (ETFC). He also bought new stakes in American Eagle Outfitters (AEO), Forest Oil (FST), McGraw Hill (MHP), Microsoft (MSFT), NYSE Euronext (NYX) and Qualcomm (QCOM). Cooperman doubled his stake in Apple (AAPL) as well.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!